glp-1 drugs safe Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity glp 1 weight loss medication
Description
Diabetic Med (2022) 39(3):e14780
SUSTAIN-6 Investigators
This proportionality-based approach prioritizes early identification of constraint-sensitive drift rather than indiscriminate supplementation
In this article: While prescription weight-loss medications in general are nothing new, there is a category of them that is: GLP-1s, or glucagon-like peptide-1 receptor agonists
Like Ozempic, Mounjaro is not included in the GLP-1 Bridge program because it carries a diabetes indication rather than a weight-loss indication
Combining semaglutide with lifestyle changes can significantly aid weight loss
